Current Landscape of Adoptive Cell Therapy and Challenge to Develop “Off‐The‐Shelf” Therapy for Hepatocellular Carcinoma

Documenti analoghi

• Risk of Hepatocellular Carcinoma Decreases After Antiviral Therapy–Induced HBsAg Seroclearance
  di: Han Ah. Lee, et al.
  Pubblicazione: (2025)
• Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma
  di: Jungnam Lee, et al.
  Pubblicazione: (2024)
• Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma
  di: Seung Kak Shin, et al.
  Pubblicazione: (2024)
• Forecasting the future prevalence of inflammatory bowel disease in Korea through 2048: an epidemiologic study employing autoregressive integrated moving average models
  di: Ji Eun Kim, et al.
  Pubblicazione: (2024)
• Comparison of 5‐Fluorouracil/Leucovorin and Capecitabine as Adjuvant Therapies in Biliary Tract Cancer
  di: Tae Seung Lee, et al.
  Pubblicazione: (2025)